Evidence for locus heterogeneity in the Bethlem myopathy and linkage to 2q37

Marcy C. Speer, Rup Tandan, P. Nagesh Rao, Timothy Fries, Jeffrey M. Stajich, Pieter A. Bolhuis, G. Joost Jöbsis, Jeffery M. Vance, Kristi D. Viles, Karen Sheffield, Christi James, Stephen G. Kahler, Mark Pettenati, John R. Gilbert, Peter H. Denton, Larry H. Yamaoka, Margaret A. Pericak-Vance

Research output: Contribution to journalArticlepeer-review

38 Scopus citations

Abstract

The Bethlem myopathy, a childhood onset autosomal dominant myopathy with joint contractures, has recently been localized to 21q in a series of Dutch families and the α1 and α2 subunits of type VI collagen (COL6A1 and COL6A2) have been postulated as candidate genes. We investigate a large family of French Canadian descent (family 1489) in which the Bethlem myopathy is segregating. Family 1489 is unlinked to the region of interest on 21q, thus demonstrating locus heterogeneity within the Bethlem myopathy classification. In view of the localization of the genes coding the α1 and α2 subunits of type VI collagen on chromosome 21q, we carried out linkage analysis on chromosome 2q where the α3 subunit of type VI collagen has been localized. We demonstrate linkage to markers in this region, define the region of disease gene localization, and confirm by FISH analysis that COL6A3 is located within the interval of interest making COL6A3 a feasible candidate gene for the Bethlem myopathy.

Original languageEnglish (US)
Pages (from-to)1043-1046
Number of pages4
JournalHuman molecular genetics
Volume5
Issue number7
DOIs
StatePublished - Jul 1996

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Genetics(clinical)

Fingerprint Dive into the research topics of 'Evidence for locus heterogeneity in the Bethlem myopathy and linkage to 2q37'. Together they form a unique fingerprint.

Cite this